Market Value999,389,000
Total Holdings53
File Date2019-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CRVS / Corvus Pharmaceuticals, Inc.
IRWD / Ironwood Pharmaceuticals, Inc. Call
EYRYY / Erytech Pharma
US16706W1027 / Chiasma Inc
US62857M1053 / MyoKardia, Inc.
GILD / Gilead Sciences, Inc. Call
ELAN / Elanco Animal Health Incorporated
US00448Q2012 / Achillion Pharmaceuticals, Inc.
KZR / Kezar Life Sciences, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
DVAX / Dynavax Technologies Corporation
CORT / Corcept Therapeutics Incorporated
ASMB / Assembly Biosciences, Inc. Call
ABUS / Arbutus Biopharma Corporation
FGEN / FibroGen, Inc. Call
SPRO / Spero Therapeutics, Inc.
/ Array BioPharma, Inc.
KDMN / Kadmon Holdings Inc
RARE / Ultragenyx Pharmaceutical Inc.
ONCE / Spark Therapeutics, Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
APTX / Aptinyx Inc.
FTSV / Forty Seven, Inc.
AFMD / Affimed N.V.
SGMO / Sangamo Therapeutics, Inc.
US00972L1070 / Akcea Therapeutics Inc.
ONTX / Onconova Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc. Call
CELG / Celgene Corp. Call
JNCE / Jounce Therapeutics Inc Call
WVE / Wave Life Sciences Ltd.
US2103731061 / Constellation Pharmaceuticals Inc
NKTR / Nektar Therapeutics Call
US33830X1046 / Five Prime Therapeutics Inc
IMDZ / Immune Design Corp.
0PP / Portola Pharmaceuticals Inc
DRNA / Dicerna Pharmaceuticals Inc
RCUS / Arcus Biosciences, Inc.
PRTA / Prothena Corporation plc
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Put
MGTA / Magenta Therapeutics Inc
ASMB / Assembly Biosciences, Inc.
RUBY / Rubius Therapeutics, Inc.
INFI / Infinity Pharmaceuticals Inc.
NLTX / Neoleukin Therapeutics, Inc.
UBX / Unity Biotechnology, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
ACRS / Aclaris Therapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
RCKT / Rocket Pharmaceuticals, Inc.
PRQR / ProQR Therapeutics N.V.
IONS / Ionis Pharmaceuticals, Inc.
CRIS / Curis, Inc.
FGEN / FibroGen, Inc.
MRTX / Mirati Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Call
SLDB / Solid Biosciences Inc.
SURF / Surface Oncology Inc
ARVN / Arvinas, Inc.
MGNX / MacroGenics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
CRSP / CRISPR Therapeutics AG
AVRO / AVROBIO, Inc.
KURA / Kura Oncology, Inc.
XNCR / Xencor, Inc.
MRSN / Mersana Therapeutics, Inc.